Takeda Pharmaceutical: revenue 2021

In fiscal year 2021, the Japanese pharmaceutical company Takeda Pharmaceutical Co., Ltd generated a revenue of close to 3.6 trillion Japanese yen, the highest amount within the observed time frame, up from around 3.2 trillion yen in the previous fiscal year.
The company mainly focuses on the therapeutic areas oncology, gastroenterology and neuroscience.

Revenue of Takeda Pharmaceutical Co., Ltd. from fiscal year 2012 to 2021 (in trillion Japanese yen)

Characteristic	Revenue in trillion Japanese yen
2021	3.57
2020	3.2
2019	3.29
2018	2.1
2017	1.77
2016	1.73
2015	1.81
2014	1.78
2013	1.69
2012	1.56

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

June 2022

More information

Region

Japan

Survey time period

fiscal years 2012 to 2021; the company’s fiscal year starts on April 1 of the stated year and ends on March 31 of the following year

Special properties

consolidated data of Takeda Pharmaceutical Co., Ltd. and its subsidiaries

Supplementary notes

Takeda has adopted International Financial Reporting Standards (IFRS) from fiscal 2013 ended March 31, 2014 and the disclosure information in this material is based on IFRS.

100 Japanese yen equal 0.74 U.S. dollars or 0.70 euros as of December 2022.
Figures prior to 2017 come from previous reporting.
Figures have been rounded.

Citation formats